08:00 , Dec 9, 2013 |  BC Week In Review  |  Financial News

Bioxodes completes venture financing

Bioxodes S.A. , Marche-en-Famenne, Belgium   Business: Cardiovascular   Date completed: 11/26/13   Type: Venture financing   Raised: €2.6 million ($3.5 million)   Investors: European Regional Development Fund; Retech; angel investors  ...
07:00 , Oct 15, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Arterial thrombosis; venous thromboembolism (VTE) Factor XII; Factor XI; kallikrein Studies in human plasma and in rodents suggest that a compound derived from tick...